Psomagen Inc
950200
Company Profile
Business description
Psomagen Inc provides total genomic solutions for both clinical and research purposes. It is mainly focused on end-to-end sequencing services. The company also offers services such as personal DNA tests, clinical sequencing, research sequencing, and others.
Contact
1330 Piccard Drive
Suite 103
RockvilleMD20850
USAT: +1 301 251-1007
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2026
Employees
88
Stocks News & Analysis
stocks
Major ASX miner reduces aluminium exposure
The Alcoa transaction unlocks value and sharpens ASX miners focus on base metals.
stocks
Vegemite owner’s shares remain expensive on normalising profits.
Australian dairy staple to see profits normalise with shares screening as overvalued.
stocks
Ask the analyst: Where does GYG stand following its US exit?
All roads lead back home for Guzman Y Gomez.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,037.00 | 11.20 | 0.12% |
| CAC 40 | 8,477.53 | 30.54 | -0.36% |
| DAX 40 | 25,832.52 | 53.21 | 0.21% |
| Dow JONES (US) | 52,852.66 | 47.41 | -0.09% |
| FTSE 100 | 10,649.13 | 29.90 | -0.28% |
| HKSE | 23,616.32 | 266.29 | 1.14% |
| NASDAQ | 26,161.75 | 329.08 | 1.27% |
| Nikkei 225 | 69,737.69 | 6.38 | -0.01% |
| NZX 50 Index | 13,763.10 | 144.68 | 1.06% |
| S&P 500 | 7,534.83 | 51.59 | 0.69% |
| S&P/ASX 200 | 8,831.00 | 12.70 | 0.14% |
| SSE Composite Index | 4,041.24 | 2.41 | -0.06% |